CLINICAL_TRIALS ClinicalTrials.gov record update

The Expanded Access Use of Vorasidenib in Patients With IDH1 or IDH2 Mutated Glioma

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT05592743
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:27:09.752333+00:00
Published At: 2024-11-05T00:00:00+00:00
Record Updated At: 2024-11-05
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Glioma", "Recurrence", "Disease Attributes", "Pathologic Processes", "Neoplasms, Neuroepithelial", "Neuroectodermal Tumors", "Neoplasms, Germ Cell and Embryonal", "Neoplasms by Histologic Type", "Neoplasms", "Neoplasms, Glandular and Epithelial", "Neoplasms, Nerve Tissue"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2024-11-05"
protocolSection.identificationModule.nctId: "NCT05592743"
protocolSection.identificationModule.officialTitle: "The Expanded Access Use of Vorasidenib in Patients With IDH1 or IDH2 Mutated Glioma"
protocolSection.statusModule.overallStatus: "APPROVED_FOR_MARKETING"
protocolSection.designModule.phases: []
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.